Through in vitro and in vivo models of MI, the authors demonstrated that Dioscin treatment significantly attenuates ferroptosis in cardiomyocytes, as evidenced by a decrease in lipid peroxidation by about 19% and preserved mitochondrial integrity. Overall, the findings suggested that Dioscin holds promise as a therapeutic agent against post-MI cardiac injury by mitigating ferroptosis via the suppression of ER stress.
Countstar Connection
Researchers used Countstar (model not specified) to assess cell numbers in the study's cell samples during quality assessment in the 2025 Molecular medicine study.
